Financials data is unavailable for this security.
Cash flow in PLNView more
In 2023, Captor Therapeutics SA increased its cash reserves by 6.57%, or 4.67m. Cash Flow from Financing totalled 36.94m or 279.83% of revenues. In addition the company used 52.20m for operations while cash from investing totalled 19.93m.
Cash flow per share | -9.16 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 10.87 |
---|---|
Tangible book value per share | 10.59 |
More ▼
Balance sheet in PLNView more
Current ratio | 2.82 |
---|---|
Quick ratio | -- |
Total debt/total equity | 0.1253 |
---|---|
Total debt/total capital | 0.1114 |
More ▼